Virtual reality technology is showing promise in augmenting traditional assessment and interventional strategies. A look at some lines of investigation.
Recent technological advances in fundus autofluorescence and the advent of ultra-widefield imaging are providing insights into retinal physiology and pathophysiology
Online in Advance of Print: David W. Parke II, MD, Academy CEO, talks about the IRIS Registry (Intelligent Research in Sight)
Don't miss the EyeNet Corporate Lunches on Saturday, Sunday, and Monday.
And finally, the October CME supplement from MedEdicus can be found here: Targeting Anterior Uveitis: A Focus on Iontophoresis and Other Advanced Technologies.
|AdvertisementLearn about mucopolysaccharidosis type I, or MPS 1 disease, courtesy of Sanofi Genzyme.
Publications for This Year's AAO
News in Review